Outpatient antibiotic use in the United States: Time to get smarter

Clinical Infectious Diseases

Volumn 53, Issue 7, 2011, Pages 640-643

  Huttner, Benedikt ^a   Samore, Matthew ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; MACROLIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; EDITORIAL; ETHIOPIA; HEALTH CARE; HOSPITAL; HUMAN; INCIDENCE; NONHUMAN; OTITIS MEDIA; OUTPATIENT; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINUSITIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; UNITED STATES;

EID: 80052502981     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir449     Document Type: Editorial

References (45)

1. Huang SS, Johnson KM, Ray GT, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011; 29:3398-412.
2. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, Streptococcus pneumoniae, 2009. 2010. http://www.cdc.gov/abcs/reports-findings/survreports/ spneu09.pdf. Accessed 5 July 2011.
3. Hicks L, Chien Y-W, Taylor T, Haber M, Klugman K. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011; 53:632-640.
4. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and betalactam consumption in Spain (1979-1997). J Antimicrob Chemother 2000; 46:767-73.
5. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8:278-82. (Pubitemid 34266265)
6. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10:514-7. (Pubitemid 38314485)
7. Livermore DM, Reynolds R, Stephens P, et al. Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents 2006; 28:273-9. (Pubitemid 44425402)
8. Bergman M, Huikko S, Huovinen P, Paakkari P, Seppala H. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2006; 50: 3646-50. (Pubitemid 44684876)
9. Riedel S, Beekmann SE, Heilmann KP, et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007; 26:485-90. (Pubitemid 47025039)
10. van de Sande-Bruinsma N, Grundmann H, Verloo D, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14:1722-30.
11. Van Eldere J, Mera RM, Miller LA, Poupard JA, Amrine-Madsen H. Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location. Antimicrob Agents Chemother 2007; 51:3491-7. (Pubitemid 47519334)
12. Melander E, Ekdahl K, Jonsson G, Molstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 2000; 19:1172-7. (Pubitemid 32003362)
13. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002; 8:347-54. (Pubitemid 34415194)
14. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003; 9:424-30. (Pubitemid 36460076)
15. Samore MH, Lipsitch M, Alder SC, et al. Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol 2006; 163:160-70. (Pubitemid 43068985)
16. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis 2001; 32:1044-54. (Pubitemid 32299640)
17. Skalet AH, Cevallos V, Ayele B, et al. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med 2010; 7:e1000377.
18. Coco A, Vernacchio L, Horst M, Anderson A. Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics 2010; 125:214-20.
19. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340:c2096.
20. Franck AJ, Smith RE. Antibiotic use for acute upper respiratory tract infections in a veteran population. J Am Pharm Assoc (2003) 2010; 50:726-9.
21. Nord CE, Peterson J, Ambruzs M, Fisher AC. Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults. Curr Med Res Opin 2009; 25:1461-7.
22. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007; 369:482-90. (Pubitemid 46209315)
23. Eisenblatter M, Klaus C, Pletz MW, et al. Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers. Eur J Clin Microbiol Infect Dis 2008; 27:1087-92.
24. Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to2002. Am J Med 2005; 118:259-68. (Pubitemid 40312637)
25. Bhavnani SM, Hammel JP, Jones RN, Ambrose PG. Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 2005; 51:31-7. (Pubitemid 40040565)
26. Adam HJ, Hoban DJ, Gin AS, Zhanel GG. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacinresistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents 2009; 34:82-5.
27. Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R. Variation in outpatient antibiotic prescribing in the United States. Am J Manag Care 2009; 15:861-8.
28. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005; 20:697-702. (Pubitemid 41141000)
29. Vander Stichele RH, ElseviersMM, FerechM, Blot S, Goossens H. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28. (Pubitemid 39312466)
30. Spellberg B, Blaser M, Guidos RJ, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011; 52(Suppl 5):S397-428.
31. Hicks L, Suda K, Roberts R, Hunkler R, Taylor T, Danziger L. Antimicrobial prescription data reveal wide geographic variability in antimicrobial use in the United States, 2009. In: 48th Annual Meeting of the Infectious Diseases Society of America 2010. Vancouver, 2010. http://idsa.confex. com/idsa/2010/webprogram/Paper3571.html. Accessed 5 July 2011.
32. Akkerman AE, Kuyvenhoven MM, Verheij TJ, van Dijk L. Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement rates. Pharmacoepidemiol Drug Saf 2008; 17: 378-83. (Pubitemid 351566354)
33. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009; 302:758-66.
34. Kronman MP, Hersh AL, Feng R, Huang YS, Lee GE, Shah SS. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007. Pediatrics 2011; 127:411-8.
35. Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics 2011; 127:28-34.
36. Vernaz N, Huttner B, Muscionico D, et al. Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 2011; 66:928-35.
37. Gallini A, Degris E, Desplas M, et al. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacinresistant Escherichia coli in a university hospital. J Antimicrob Chemother 2010; 65:2650-7.
38. Huttner B, Goossens H, Verheij T, Harbarth S. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in highincome countries. Lancet Infect Dis 2010; 10:17-31.
39. Roehr B. Campaigns to reduce antibiotic use in the US cannot compete with drug advertising, study says. BMJ 2009; 339:b3785.
40. Get smart: know when antibiotics work. Partners: state and county-based appropriate antibiotic use programs Available at: http://www.cdc.gov/getsmart/ program-planner/state-summaries.html. Accessed 1 June 2011.
41. Masiero G, Filippini M, Ferech M, Goossens H. Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 2010; 55:469-78.
42. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009; 338:b2242.
43. Kesselheim AS, Outterson K. Fighting antibiotic resistance: Marrying new financial incentives to meeting public health goals. Health Aff (Millwood) 2010; 29:1689-96.
44. US supermarkets redefine antibiotic misuse. Lancet Infect Dis 2009; 9:265.
45. Del Mar C. Prescribing antibiotics in primary care. BMJ 2007; 335:407-8. (Pubitemid 47372631)